Homechevron_rightAll Peptideschevron_rightBPC-157 Injection Pen

verified_user

Safety data sheet

Standardized safety protocols and material specifications for professional use.

analytics

Certificate of Analysis

Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-bpc-157-injection-pen-10mg

Official Product Data Sheet

BPC-157 Injection Pen (10mg)

High >98% Purity

Vial Contents

10 mg BPC-157 (3 mL pre-filled injection pen)

Includes

Ready-to-use multi-dose injection pen — no mixing required

Form

Pre-filled multi-dose pen

Purity

≥98%, third-party verified

Sequence

Body Protection Compound

Molecular Formula

See chemical properties

Molecular Mass

1419.5 g/mol

CAS No.

137525-51-0

Solubility

Concentration: ≈3.33 mg/mL | Per click: 1 unit ≈ 33.33 mcg (0.033 mg)

Storage

Refrigerate at 2–8 °C. Protect from light. Do not freeze.

Authorized Resellers

Available through our trusted partners

verifiedVerified

123peptide.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new

verifiedVerified

Depeptidenwinkel.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new

View all authorized resellersshopping_cart

swipe_rightSwipe to see all tabs

Scientific Background

BPC-157 is a 15-amino-acid synthetic pentadecapeptide derived from a protein found in gastric juice. It promotes tissue repair and regeneration through VEGF upregulation, angiogenesis, nitric oxide modulation, and growth factor pathway activation. Pre-clinical research consistently shows accelerated healing across muscle, tendon, ligament, bone, and gastrointestinal tissues.

Intended Research Use

Muscle, tendon, and ligament repair research
Angiogenesis and VEGF pathway studies
Gastrointestinal healing and gut permeability research
Anti-inflammatory and neuroprotective studies
Bone healing and joint repair research

menu_bookScientific Publications

article

Curr Pharm Des (2011)

Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/21861822/

article

Curr Pharm Des (2018)

BPC 157 as potential agent rescuing from cancer cachexia

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/29788891/

warning

FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.

Possible stacks with other peptides

Synergistic combinations for enhanced research outcomes

BPC-157 combines powerfully with other regenerative and immune-supporting peptides.

TB-500 5mg (5mg vial)

arrow_forward

myo-tb-500-5mg

Synergistic tissue regeneration and angiogenesis — TB-500 provides systemic actin-regulatory repair while BPC-157 promotes local angiogenesis and growth factor activation.

GHK-Cu 50mg (50mg vial)

arrow_forward

myo-ghk-cu-50mg

Enhanced wound healing and skin rejuvenation — copper peptide collagen synthesis complements BPC-157's growth factor pathway activation.

Thymosin Alpha-1 10mg (10mg vial)

arrow_forward

myo-thymosin-alpha-1-10mg

Immune modulation during recovery — Thymosin Alpha-1's T-cell regulatory activity complements BPC-157's tissue repair for comprehensive healing support.

schedule

Cycling Note: Standard protocol: 8–12 weeks for acute injury research. Rotate injection sites daily. May be used continuously for chronic GI research.

Also Available

Vial

BPC-157

5mg

Vial

BPC-157

10mg